Handelsbanken Fonder
AXSM icon

Handelsbanken Fonder’s Axsome Therapeutics AXSM Stock Holding History

Handelsbanken Fonder’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
42,400
+29,000
+216% +$6.29M 0.03% 378
2026
Q1 		$2.27M Buy
13,400
+800
+6% +$138K 0.01% 690
2025
Q4 		$2.3M Buy
12,600
+1,200
+11% +$168K 0.01% 688
2025
Q3 		$1.39M Buy
11,400
+600
+6% +$67.6K ﹤0.01% 872
2025
Q2 		$1.13M Sell
10,800
-1,000
-8% -$106K ﹤0.01% 909
2025
Q1 		$1.38M Hold
11,800
– – 0.01% 810
2024
Q4 		$998K Sell
11,800
-500
-4% -$46K ﹤0.01% 965
2024
Q3 		$1.1M Buy
12,300
+2,000
+19% +$175K ﹤0.01% 902
2024
Q2 		$829K Sell
10,300
-400
-4% -$29.6K ﹤0.01% 913
2024
Q1 		$854K Buy
10,700
+3,000
+39% +$252K ﹤0.01% 904
2023
Q4 		$613K Buy
7,700
+900
+13% +$60.2K ﹤0.01% 1041
2023
Q3 		$475K Buy
6,800
+600
+10% +$44.9K ﹤0.01% 1076
2023
Q2 		$446K Buy
6,200
+600
+11% +$44.3K ﹤0.01% 1129
2023
Q1 		$345K Buy
5,600
+1,400
+33% +$92K ﹤0.01% 1209
2022
Q4 		$324K Sell
4,200
-2,300
-35% -$137K ﹤0.01% 1201
2022
Q3 		$290K Hold
6,500
– – ﹤0.01% 1268
2022
Q2 		$249K Sell
6,500
-1,000
-13% -$31.6K ﹤0.01% 1426
2022
Q1 		$310K Hold
7,500
– – ﹤0.01% 1500
2021
Q4 		$283K Buy
7,500
+1,300
+21% +$47.8K ﹤0.01% 1627
2021
Q3 		$204K Hold
6,200
– – ﹤0.01% 1654
2021
Q2 		$418K Buy
6,200
+200
+3% +$12K ﹤0.01% 1506
2021
Q1 		$340K Hold
6,000
– – ﹤0.01% 1399
2020
Q4 		$489K Hold
6,000
– – ﹤0.01% 1172
2020
Q3 		$428K Hold
6,000
– – ﹤0.01% 1067
2020
Q2 		$494K Buy
+6,000
New +$462K ﹤0.01% 966

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Handelsbanken Fonder's AXSM Position: Q2 2026 in Review

Handelsbanken Fonder increased its Axsome Therapeutics (AXSM) stake by 216% in Q2 2026, buying an estimated $6.29M and bringing the position to 42,400 shares worth $10.4M. The position accounts for 0.03% of the portfolio, ranked #378.

Handelsbanken Fonder first reported a position in AXSM in Q2 2020 and has held it in 25 quarters since. 120 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Handelsbanken Fonder held 42,400 shares of Axsome Therapeutics worth $10.4M as of Q2 2026.
  • Handelsbanken Fonder bought 29,000 Axsome Therapeutics shares in Q2 2026, an estimated $6.29M.
  • Axsome Therapeutics made up 0.03% of Handelsbanken Fonder's portfolio in Q2 2026, its #378 holding.
  • Handelsbanken Fonder first reported a position in Axsome Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • 120 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.